Estrogen replacement therapy is the most effective approach to date for slowing or stopping bone mineral loss due to osteoporosis. Research has shown that estrogen therapy is most effective when given early in menopause, when bones thin the fastest. The purpose of estrogen replacement is to prevent further bone loss. Although estrogen may reverse bone loss slightly, most of what was lost can’t be regained. Since estrogen therapy does carry potential serious side effects, physicians are cautious in prescribing it to all patients at risk for osteoporosis.

Calcium supplements have been advertised as an aid in preventing or slowing bone thinning. Adequate calcium intake in the formative years is important for normal bone development. A balanced daily diet comprised of all the essential vitamins and minerals is necessary for all persons of all ages to maintain a healthy body.

Regular weight-bearing exercise such as walking, tennis, running etc. has been associated with greater bone density, thus reinforcing the need for an active life style for overall good health.

There is currently research on new therapies for treating osteoporosis. Some of the newer drugs (Calcitonin, Fosamax, Fluorides) have given a new hope in the fight against osteoporosis.

What’s best for you?

Talk to your doctor about risk, prevention, and therapy-and remember that each person must be evaluated individually.

White and Asian women are more severely affected by osteoporosis than black and Hispanic women. Black and Hispanic women have denser, stronger bones throughout their lives, making them half as likely to suffer fractures from osteoporosis as white and Asian women of the same age. Other factors that increase risk are early menopause, a family history of osteoporosis, thin body build, inactivity, smoking and excessive use of alcohol and chronic steroid use. 

Unfortunately, symptoms usually don’t exist until the damage has been done and bones are so weak that they break. Only radiologic tests (special X-rays) can show bone mineral loss. The problem with the tests is that they don’t show early bone loss or indicate very accurately whether the loss is at a serious level.